NFE2L2 and hepatocellular carcinoma: NRF2 is likely another important regulator of antioxidant defense, because inhibition of the p62-KEAP1-NRF2 antioxidant signaling pathway may significantly enhance the cytotoxicity of sorafenib on HCC cells both in vivo and in vitro[27].